These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7734099

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
    Wong PC, Hart SD, Duncia JV, Timmermans PB.
    Eur J Pharmacol; 1991 Sep 24; 202(3):323-30. PubMed ID: 1748155
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    Widdop RE, Gardiner SM, Kemp PA, Bennett T.
    Br J Pharmacol; 1992 Nov 24; 107(3):873-80. PubMed ID: 1472980
    [Abstract] [Full Text] [Related]

  • 25. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F, Natov S, Martinez F, Lacour B, Hannedouche TP.
    Clin Sci (Lond); 1996 Mar 24; 90(3):205-13. PubMed ID: 8777826
    [Abstract] [Full Text] [Related]

  • 26. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD.
    J Pharmacol Exp Ther; 1994 Nov 24; 271(2):804-10. PubMed ID: 7965799
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2001 Apr 24; 15(2):143-50. PubMed ID: 11468024
    [Abstract] [Full Text] [Related]

  • 32. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A, Witte K, Lemmer B.
    J Cardiovasc Pharmacol; 1995 Aug 24; 26(2):214-21. PubMed ID: 7475045
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S, Sato T, Furuta K, Hase K, Ohkura Y, Fukai C, Kosakai K, Wakabayashi S, Tomiyama A.
    J Cardiovasc Pharmacol; 1995 Jan 24; 25(1):22-9. PubMed ID: 7723348
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC, Quan ML, Saye JM, Bernard R, Crain EJ, McCall DE, Watson CA, Zaspel AM, Smith RD, Wexler RR.
    J Cardiovasc Pharmacol; 1995 Sep 24; 26(3):354-62. PubMed ID: 8583775
    [Abstract] [Full Text] [Related]

  • 36. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
    Bertolino F, Valentin JP, Maffre M, Jover B, Bessac AM, John GW.
    J Pharmacol Exp Ther; 1994 Feb 24; 268(2):747-52. PubMed ID: 8113986
    [Abstract] [Full Text] [Related]

  • 37. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL, Zhao X, Sun X, Hedner T.
    J Pharm Pharmacol; 1996 Aug 24; 48(8):829-33. PubMed ID: 8887734
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.